Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach

International Journal of Molecular Sciences
Björn ReuterMarc Fatar

Abstract

Cerebral amyloid angiopathy (CAA) is characterized by vascular deposition of amyloid β (Aβ) with a higher incidence of cerebral microbleeds (cMBs) and spontaneous hemorrhage. Since statins are known for their benefit in vascular disease we tested for the effect on CAA. APP23-transgenic mice received atorvastatin-supplemented food starting at the age of eight months (n = 13), 12 months (n = 7), and 16 months (n = 6), respectively. Controls (n = 16) received standard food only. At 24 months of age cMBs were determined with T2*-weighted 9.4T magnetic resonance imaging and graded by size. Control mice displayed an average of 35 ± 18.5 cMBs (mean ± standard deviation), compared to 29.3 ± 9.8 in mice with eight months (p = 0.49), 24.9 ± 21.3 with 12 months (p = 0.26), and 27.8 ± 15.4 with 16 months of atorvastatin treatment (p = 0.27). In combined analysis treated mice showed lower absolute numbers (27.4 ± 15.6, p = 0.16) compared to controls and also after adjustment for cMB size (p = 0.13). Despite to a non-significant trend towards fewer cMBs our results failed to provide evidence for beneficial effects of long-term atorvastatin treatment in the APP23-transgenic mouse model of CAA. A higher risk for bleeding complications was not ...Continue Reading

References

Mar 1, 1987·Stroke; a Journal of Cerebral Circulation·H V Vinters
Jul 31, 2002·Brain Pathology·Tamas ReveszBlas Frangione
Dec 1, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Anetta UndasKenneth G Mann
Feb 25, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Neil A TurnerKaren E Porter
Mar 12, 2005·Journal of the Neurological Sciences·Jin-Moo LeeJian Xu
Jul 27, 2006·Acta Neurologica Scandinavica. Supplementum·B WolozinA McKee
Dec 14, 2007·Neurology·L B GoldsteinUNKNOWN SPARCL Investigators
Feb 26, 2008·Journal of Vascular Surgery·Hagen KunteLutz Harms
May 10, 2008·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Uwe Himmelreich, Mathias Hoehn
Sep 24, 2008·Antioxidants & Redox Signaling·Jeffrey R Jacobson
May 16, 2009·Stroke; a Journal of Cerebral Circulation·Eric E Smith, Steven M Greenberg
Sep 25, 2010·Annals of Neurology·Gregory A DierksenSteven M Greenberg
Dec 23, 2011·Annals of Neurology·Anand Viswanathan, Steven M Greenberg
Apr 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xin-Kang TongEdith Hamel
Jul 26, 2012·Stroke; a Journal of Cerebral Circulation·Diogo C HaussenMagdy Selim
Aug 30, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Sotirios GiannopoulosRandolph S Marshall
Jul 19, 2013·Neurology·Andreas CharidimouDavid John Werring
Mar 4, 2014·Lancet Neurology·Steven M GreenbergDavid J Werring
Apr 10, 2014·Stroke; a Journal of Cerebral Circulation·José Rafael RomeroSudha Seshadri
Jul 10, 2014·Stroke; a Journal of Cerebral Circulation·Björn ReuterMarc Fatar
Dec 6, 2014·Translational Stroke Research·Björn ReuterMarc Fatar
Jul 15, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Ana Castro CaldasJosé Manuel Ferro

❮ Previous
Next ❯

Citations

Nov 14, 2020·Journal of the Neurological Sciences·Aristeidis H KatsanosUNKNOWN International META-MICROBLEEDS Initiative

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

Power
Leica IM50 Image Manager
SPSS
ImageJ

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.